A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of Intranasal Single Dose SB-705498 on the Response to Intranasal Capsaicin Challenge in Non-allergic Rhinitis Patients.
Phase of Trial: Phase II
Latest Information Update: 06 Dec 2016
At a glance
- Drugs GSK 705498 (Primary)
- Indications Rhinitis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 05 Aug 2013 Results published in the British Journal of Clinical Pharmacology.
- 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.
- 26 Sep 2011 New trial record